Registered entities
Novocure Ltd
Reg. No. 1645113United States
NOVOCURE (USA), INC.
Reg. No. 205063536United States
Innovation
12 patent families (9 granted) — focus: Human necessities; filing pace slowing. Cited 1,088 times.
| Year | Filings |
|---|---|
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Social engagement
Social engagement: 73.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include Johnson & Johnson Innovation – JJDC, Index Ventures, Pfizer Venture Investments; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 3 | 20% |
| Angel & family office | 1 | 7% |
| Other / undisclosed | 3 | 20% |
Recent activity
1 Jul 2026
Milestone
regulatory
1 Jul 2026
Event
ESMO - European Society for Medical Oncology Gastrointestinal Cancers Congress (ESMO GI)
30 Jun 2026
Milestone
regulatory